Exelixis
EXEL
#1613
Rank
C$14.85 B
Marketcap
$53.09
Share price
-1.08%
Change (1 day)
70.88%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company